Abstract
This chapter examines the range of sciences and technologies that converge around sports and the implications of this for issues of fairness and ethics. First, it outlines some of the recent scientific developments that speak to the convergence of disciplines pertinent to sports enhancements. Second, it considers the consequences of convergence within sport, inquiring into the practical ethical issues it provokes. Finally, it explores examples of technological effect in sport, which, collectively, articulate how far ranging are the many ways in which innovation converges on sports. In so doing, it provides a taxonomy of innovations which reveal the complexity of technological change in sports and the challenge of isolating artifice from nature.
Similar content being viewed by others
References
American Academy of Pediatrics (2005) Policy statement: use of performance-enhancing substances. Pediatrics 115:1103–1106
Australia Law Reform Commission (2003) ALRC 96: essentially yours
Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N, Sweeney HL (1998) Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A 95:15603–15607
Bjerklie D (1993) High-tech olympians. Technol Rev 96:22–30
Brody H (2000) An overview of racket technology. In: Haake SA, Coe AO (eds) Tennis science and technology. Blackwell, London, pp 43–48
Brull D, Dhamrait S, Myerson s, Erdmann J, Regitz-Zagrosek V, World M, ... Montgomery H (2001) Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. The Lancet, 358:1155–1156
Busch A (1998) Design for sports: the cult of performance. Thames & Hudson, London
Denham BE (1999a) Building the agenda and adjusting the frame: how the dramatic revelations of lylle alzado impacted mainstream press coverage of anabolic steroid use. Sociol Sport J, 16, 1–15
Denham BE (1999b) On drugs in sports in the aftermath of Flo-Jo’s death, Big Mac’s attack. Journal of Sport and Social Issues, 23(3), 362–367
Donati A (2005). Criminality in the International Doping Trade. World Anti-Doping Agency, Presentation. Available: http://www.playthegame.org/upload/sandro_donati_-_criminality_in_the_international_doping_trade.pdf. Accessed 25 July 2015
Fotheringham W (1996) Cycling: hour of pain, shame or glory. The Guardian, London, 14
Fraleigh WP (1984) Performance-enhancing drugs in sport: the ethical issue. J Philos Sport XI:23–29
Gardner R (1989) On performance-enhancing substances and the unfair advantage argument. J Philos Sport XVI:59–73
Gayagay G, Yu B, Hambly B, Boston T, Hahn A, Celermajer DS, Trent RJ (1998) Elite endurance athletes and the ACE I allele – the role of genes in athletic performance. Hum Genet 1031:48–50
Gelberg JN (1995) The lethal weapon: how the plastic football helmet transformed the game of football, 1939–1994. Bull Sci Technol Soc 155–6:302–309
Goldspink G (2001) Gene expression in skeletal muscle. Biochem Soc Trans 30:285–290
Hoberman JM (1992) Mortal engines: the science of performance and the dehumanization of sport. The Free Press, New York, Reprinted 2001, the Blackburn Press
Hon O, Coumans B (2007) The continuing story of nutritional supplements and doping infractions. Br J Sports Med 41:800–805
Hummel RL, Foster GS (1986) A sporting chance: relationships between technological change & concepts of fair play in fishing. J Leis Res 181:40–52
Inizan F (1994) Masters and slaves of time. Olympic Rev 320:306–310
Lamsam C, Fu FH, Robbins PD, Evans CH (1997) Gene therapy in sports medicine. Sports Med 252:73–77
Levine BD (2006) Should “Artificial” high altitude environments be considered doping? Scand J Med Sci Sports 16(5):297–301
Lin J, Wu H, Tarr PT, Zhang C, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R, Spiegelmann BM (2002) Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418:797–801
Loland S, Murray TH (2007) The ethics of the use of technologically constructed high-altitude environments to enhance performances in sport. Scand J Med Sci Sports 17:193–195
Magdalinski T (2000) Performance technologies: drugs and Fastskin at the Sydney 2000 Olympics. Media Int Australia 97:59–69
Martinek V, Fu FH et al (2000) Gene therapy and tissue engineering in sports medicine. Phys Sportsmed 282. http://www.physsportsmed.com/issues/2000/02_00/huard.htm
Miah A (2000a) Chapter 27: Climbing upwards of climbing backwards? The technological metamorphoses of climbing and mountaineering. In: Messenger N, Patterson W, Brook D (eds) The science of climbing and mountaineering. Human Kinetics, London
Miah A (2000b) The engineered athlete: human rights in the genetic revolution. Culture Sport Soc 33:25–40
Miah A (2000c) “New balls please”: tennis, technology, and the changing game. In: Haake SA, Coe AO (eds) Tennis science and technology. Blackwell, London, pp 285–292
Miah A (2004) Genetically modified athletes: biomedical ethics, gene doping and sport. Routledge, London/New York
Montgomery H, Marshall R, Hemingway H, Myerson S, Clarkson P, Dollery C, Hayward M, Holliman DE, Jubb M, World M, Thomas EL, Brynes AE, Saeed N, Barnard M, Bell JD, Prasad K, Rayson M, Talmud PJ, Humphries SE (1998) Human gene for physical performance. Nature 393:221–222
Montgomery H, Clarkson P, Barnard M, Bell J, Brynes A, Dollery C, Hajnal J, Hemingway H, Mercer D, Jarman P, Marshall R, Prasad K, Rayson M, Saeed N, Talmud P, Thomas L, Jubb M, World M, Humphries S (1999) Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet 353(13):541–545
Munthe C (2000) Selected champions: making winners in the age of genetic technology. In: Tännsjö T, Tamburrini C (eds) Values in sport: elitism, nationalism, gender equality, and the scientific manufacture of winners. E & F.N. Spon, London/New York, pp 217–231
Murray TH (1983) The coercive power of drugs in sports. Hastings Cent Rep 13(4):24–30
Murray TH (1984) Drugs, sports, and ethics. In: Murray TH, Gaylin W, Macklin R (eds) Feeling good and doing better. Humana Press, T. Clifton, pp 107–126
Murray TH (1986a) Guest editorial: drug testing and moral responsibility. Phys Sportsmed 1411:47–48
Murray TH (1986b) Guest editorial: human growth hormone in sports: no. Phys Sportsmed 145:29
Parens E (ed) (1998) Enhancing human traits: ethical and social implications, Hastings center studies in ethics. Georgetown University Press, Washington, DC
Science and Technology Select Committee (2006) New inquiry: human enhancement technologies in sport. Select Committee for Science and Technology, British Government, London
Sekera MH, Ahrens BD et al (2005) Another designer steroid: discovery, synthesis, and detection of “madol” in urine. Rapid Commun Mass Spectom 19:781–784
Svensson EC, Black HB, Dugger DL, Tripathy SK, Goldwasser E, Hao Z, Chu L, Leiden JM (1997) Long-term erythropoietin expression in rodents and non-human primates following intramuscular injection of a replication-defective adenoviral vector. Hum Gene Ther 815:1797–1806
Sweney M (2015) ‘Beach body ready’ ad banned from returning to tube, watchdog rules. The Guardian. Available Online http://www.theguardian.com/media/2015/apr/29/beach-body-ready-ad-faces-formal-inquiry-as-campaign-sparks-outrage. Accessed 1 May 2015
Templeton S.-K (2006) Footballers use babies for “repair kits.” The Sunday Times. London. Retrieved from http://www.thesundaytimes.co.uk/sto/news/uk_news/article166119.ece
Tenner E (1996) Why things bite back: predicting the problems of progress. Fourth Estate, London
The U.S. President’s Council on Bioethics (2002a) Session 4: enhancement 2: potential for genetic enhancements in sports. The President’s Council on Bioethics, Washington, DC. Hypertext document, available at http://www.bioethics.gov/200207/session4.html
The U.S. President’s Council on Bioethics (2002b) Sixth meeting: session 7: enhancement 5: genetic enhancement of muscle. The President’s Council on Bioethics, Washington, DC. Hypertext document, available at http://www.bioethics.gov/transcripts/sep02/session7.html
The U.S. President’s Council on Bioethics (2003) Beyond therapy: biotechnology and the pursuit of happiness. President’s Council on Bioethics, Washington, DC
World Anti-Doping Agency (2005) The Stockholm declaration. World Anti-Doping Agency.
World Anti-Doping Agency (2009) World Anti-Doping Code, Montreal WADA.
World Anti-Doping Agency (2015) World anti-doping code. Prohibited classes of substances and prohibited methods
World Anti-Doping Agency (2014) World Anti-Doping Code, WADA. Available at: https://www.wada-ama.org/en/resources/the-code/world-anti-doping-code. Accessed 25 July 2015
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this entry
Cite this entry
Miah, A. (2015). Human Enhancement in Sports. In: Bainbridge, W., Roco, M. (eds) Handbook of Science and Technology Convergence. Springer, Cham. https://doi.org/10.1007/978-3-319-04033-2_85-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-04033-2_85-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-04033-2
eBook Packages: Springer Reference Computer SciencesReference Module Computer Science and Engineering